PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation. / Kroner, Antje; Schwab, Nicolas; Ip, Chi Wang et al.
in: PLoS ONE, Jahrgang 4, Nr. 2, e4405, 06.02.2009.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

Kroner, A, Schwab, N, Ip, CW, Leder, C, Nave, K-A, Mäurer, M, Wiendl, H & Martini, R 2009, 'PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation', PLoS ONE, Jg. 4, Nr. 2, e4405. https://doi.org/10.1371/journal.pone.0004405

APA

Kroner, A., Schwab, N., Ip, C. W., Leder, C., Nave, K.-A., Mäurer, M., Wiendl, H., & Martini, R. (2009). PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation. PLoS ONE, 4(2), Artikel e4405. https://doi.org/10.1371/journal.pone.0004405

Vancouver

Kroner A, Schwab N, Ip CW, Leder C, Nave KA, Mäurer M et al. PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation. PLoS ONE. 2009 Feb 6;4(2):e4405. doi: 10.1371/journal.pone.0004405

Bibtex

@article{a7bc95fcb62b498984560e3f7b6ecd06,
title = "PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation",
abstract = "We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype df the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/ PD-1-/-double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.",
keywords = "Chemistry",
author = "Antje Kroner and Nicolas Schwab and Ip, {Chi Wang} and Christoph Leder and Klaus-Armin Nave and Mathias M{\"a}urer and Heinz Wiendl and Rudolf Martini",
year = "2009",
month = feb,
day = "6",
doi = "10.1371/journal.pone.0004405",
language = "English",
volume = "4",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

RIS

TY - JOUR

T1 - PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation

AU - Kroner, Antje

AU - Schwab, Nicolas

AU - Ip, Chi Wang

AU - Leder, Christoph

AU - Nave, Klaus-Armin

AU - Mäurer, Mathias

AU - Wiendl, Heinz

AU - Martini, Rudolf

PY - 2009/2/6

Y1 - 2009/2/6

N2 - We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype df the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/ PD-1-/-double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.

AB - We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype df the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/ PD-1-/-double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.

KW - Chemistry

UR - http://www.scopus.com/inward/record.url?scp=84887212611&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/9a15e2d1-472e-3a33-a64b-38c827aaf3cf/

U2 - 10.1371/journal.pone.0004405

DO - 10.1371/journal.pone.0004405

M3 - Journal articles

VL - 4

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 2

M1 - e4405

ER -

Dokumente

DOI